VALSARTAN - etsinnän tulokset

Euroopan unioni - slovakki - EMA (European Medicines Agency)

entresto

novartis europharm limited - sacubitril, valsartan - zástava srdca - angiotensin ii protivníci, ďalšie kombinácie, agentov konajúcich na renin-angiotensin system - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.

Euroopan unioni - slovakki - EMA (European Medicines Agency)

neparvis

novartis europharm limited - sacubitril, valsartan - zástava srdca - Činidlá pôsobiace na systém renín-angiotenzín - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.

Euroopan unioni - slovakki - EMA (European Medicines Agency)

copalia hct

novartis europharm limited - amlodipine, valsartan, hydrochlorothiazide - vysoký tlak - angiotensin ii protivníci, kombinácie, agentov konajúcich na renin-angiotensin system, angiotensin ii antagonisty a vápnik kanálov blokátory - liečba esenciálnej hypertenzie ako substitučná liečba u dospelých pacientov, ktorých krvný tlak je adekvátne kontrolovaný kombinácia amlodipínu, valsartan a hydrochlorotiazid (hct), prijaté tri single-zložky formulácie alebo ako zložka dual a singel-zložky formulácie.